A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer
Clinical trial NCT03117920 · COMPLETED
Trial details
- NCT number
- NCT03117920
- Sponsor
- Minneamrita Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2019-07-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.